China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $755,400 | $698,972 | $717,630 | $709,833 |
| - Cash | $6,140,153 | $5,888,776 | $725,292 | $659,707 |
| + Debt | $346,527 | $301,326 | $1,070 | $2,339 |
| Enterprise Value | -$5,038,226 | -$4,888,478 | -$6,592 | $52,465 |
| Revenue | $3,778,043 | $4,516,538 | $588,092 | $498,181 |
| % Growth | -16.4% | 668% | 18% | – |
| Gross Profit | $2,831,749 | $3,394,119 | $437,398 | $372,503 |
| % Margin | 75% | 75.1% | 74.4% | 74.8% |
| EBITDA | $1,220,585 | $1,251,511 | $145,338 | $121,320 |
| % Margin | 32.3% | 27.7% | 24.7% | 24.4% |
| Net Income | $840,052 | $137,159 | $107,592 | $86,031 |
| % Margin | 22.2% | 3% | 18.3% | 17.3% |
| EPS Diluted | 1.11 | 0.18 | 0.14 | 0.11 |
| % Growth | 516.7% | 28.6% | 27.3% | – |
| Operating Cash Flow | $963,135 | $140,619 | $178,555 | $120,143 |
| Capital Expenditures | -$140,112 | -$20,334 | -$19,272 | -$14,470 |
| Free Cash Flow | $823,023 | $120,201 | $159,284 | $105,673 |